Celltrion

Vegzelma

  1. Home
  2.  / 
  3. Q Code
  4.  / Vegzelma – Q5129

Manufacturer:

Celltrion

Name:

Vegzelma

HCPCS Code Descriptor:

Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

Category:

Q Code

HCPCS:

Q5129

NDC(s):

72606-0012-01, 72606-0011-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

Vegzelma is an Oncology drug manufactured by Celltrion and administered via the Intravenous route of administration. The Q Code: Q5129 is aligned to the drug Vegzelma.

Vegzelma is an artificial antibody called IgG1 that is used to treat a variety of cancers. This medication works by blocking the VEGF protein in order to slow tumor growth. Vegzelma is manufactured by Celltrion USA and is biosimilar to the medication Avastin (J9035). Vegzelma is aligned to the HCPCS code Q5129, this code was aligned to the drug as of April 2023.

Access Pricing and More By Registering

HCPCS Added Date:

4/1/23

HCPCS Effective Date:

4/1/23

HCPCS Short Description:

Inj, vegzelma, 10 mg

Billing and Coding Guide:

Not Found

Patient Assistance:

Not Found